Current Infectious Disease Reports

, Volume 15, Issue 1, pp 25–30 | Cite as

The Role of the Manipulation of the Gut Microbiota in Obesity

Intra-abdominal Infections, Hepatitis, and Gastroenteritis (DA Bobak, Section Editor)

Abstract

The manipulation of the gut microbiota by diet, antibiotics, or probiotics could promote, prevent, or reverse the development of specific diseases, including obesity. A link has been proposed between obesity and the growth promoters (probiotics and antibiotics) that have been used in animals for more than 40 years to induce weight gain. Several species of the Lactobacillus genus that are frequently used as probiotics for human consumption merit particular attention because they are increased in the gut microbiota under high-fat diets, are more abundant in obese humans, and are selected by growth-promoter antibiotics; moreover, the administration of these bacteria in experimental models is linked to the development of obesity. However, other species or strains of the same genus are associated with an antiobesity effect. Newborns and infants are a particularly susceptible population in which the administration of antibiotics or probiotics could be related to the development of obesity in adulthood.

Keywords

Gut microbiota Manipulation Obesity Weight Antibiotics Probiotics Lactobacillus Bifidobacterium Weight gain Weight loss Newborns Bacteria Diet Meta-analysis Enterotypes 

Notes

Disclosure

No potential conflicts of interest relevant to this article were reported.

References

Papers of particular interest, published recently, have been highlighted as:• Of importance •• Of major importance

  1. 1.
    Raoult D. Human microbiome: take-home lesson on growth promoters? Nature. 2008;454:690–1.PubMedCrossRefGoogle Scholar
  2. 2.
    Raoult D. The globalization of intestinal microbiota. Eur J Clin Microbiol Infect Dis. 2010;29:1049–50.PubMedCrossRefGoogle Scholar
  3. 3.
    Pérez Guerra N, Pastrana Castro L. Probiotics: production, evaluation and uses in animal feed. Biotechnol Appl Biochem, Kerala, India.2009.ISBN: 978-81-308-0323-4.Google Scholar
  4. 4.
    Tannock GW. Probiotics a critical review. Wymondham: Horizon Scientific Press; 1999. ISBN 1-898486-15-8.Google Scholar
  5. 5.
    Raoult D. Probiotics and obesity: a link? Nat Rev Microbiol. 2009;7:616.PubMedCrossRefGoogle Scholar
  6. 6.
    Merhej V, Armougom F, Robert C, Raoult D. Genome sequence of Lactobacillus ingluviei, bacterium associated with weight gain in animals. J Bacteriol. 2012;194:5697.Google Scholar
  7. 7.
    Khan M, Raoult D, Richet H, et al. Growth-promoting effects of single-dose intragastrically administered probiotics in chickens. Br Poult Sci. 2007;48:732–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Angelakis E, Raoult D. The increase of Lactobacillus species in the gut flora of newborn broiler chicks and ducks is associated with weight gain. PLoS One. 2010;5:e10463.PubMedCrossRefGoogle Scholar
  9. 9.
    Angelakis E, Bastelica D. Ben Amara A et al. An evaluation of the effects of Lactobacillus ingluviei on body weight, the intestinal microbiome and metabolism in mice. Microb Pathog. 2012;52:61–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Ehrlich SD. Probiotics - little evidence for a link to obesity. Nat Rev Microbiol. 2009;7:901.PubMedCrossRefGoogle Scholar
  11. 11.
    Intestinal Networks in Health and Disease. Nature. 2012;474:297–336.Google Scholar
  12. 12.
    •• Angelakis E, Armougom F, Million M, Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol. 2012;7:91–109. A review linking gut microbiota and obesity with a meta-analysis reporting a consistent statistical anti-obesity effect of bifidobacteria.PubMedCrossRefGoogle Scholar
  13. 13.
    Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022–3.PubMedCrossRefGoogle Scholar
  14. 14.
    Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–31.PubMedCrossRefGoogle Scholar
  15. 15.
    Armougom F, Henry M, Vialettes B, et al. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One. 2009;4:e7125.PubMedCrossRefGoogle Scholar
  16. 16.
    • Stsepetova J, Sepp E, Kolk H, et al. Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly. Br J Nutr. 2011;105:1235–44. Another team reporting a link between gut microbiota Lactobacillus and human weight.PubMedCrossRefGoogle Scholar
  17. 17.
    Koren O, Goodrich JK, Cullender TC, et al. Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy. Cell. 2012;150:470–80.PubMedCrossRefGoogle Scholar
  18. 18.
    Santacruz A, Collado MC, Garcia-Valdes L, et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr. 2010;104:83–92.PubMedCrossRefGoogle Scholar
  19. 19.
    Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174–80.PubMedCrossRefGoogle Scholar
  20. 20.
    Zupancic ML, Cantarel BL, Liu Z, et al. Analysis of the gut microbiota in the old order amish and its relation to the metabolic syndrome. PLoS One. 2012;7:e43052.PubMedCrossRefGoogle Scholar
  21. 21.
    Ravussin Y, Koren O, Spor A, et al. Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity (Silver Spring). 2012;20:738–47.CrossRefGoogle Scholar
  22. 22.
    • Murphy EF, Cotter PD, Hogan A, et al. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut. 2012 Aug 9. epub ahead of print. High-fat diet induces a significant increase in Firmicutes and particularly Lactobacillus in mice.Google Scholar
  23. 23.
    Lam YY, Ha CW, Campbell CR, et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One. 2012;7:e34233.PubMedCrossRefGoogle Scholar
  24. 24.
    Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470–81.PubMedCrossRefGoogle Scholar
  25. 25.
    Million M, Maraninchi M, Henry M, et al. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes (Lond). 2012;36:817–25.CrossRefGoogle Scholar
  26. 26.
    Million M, Angelakis E, Paul M, et al. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog. 2012;53:100–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Zhang C, Zhang M, Pang X, et al. Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations. ISME J. 2012 Apr 12. Epub ahead of print.Google Scholar
  28. 28.
    Tannock GW. A special fondness for lactobacilli. Appl Environ Microbiol. 2004;70:3189–94.PubMedCrossRefGoogle Scholar
  29. 29.
    Turnbaugh PJ, Backhed F, Fulton L, et al. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3:213–23.PubMedCrossRefGoogle Scholar
  30. 30.
    •• Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010;328:228–31. This study confirmed that gut transplantation led to transmission of obese traits (adiposity) suggesting that modification of the intestinal flora is a contributing factor in the development of obesity.PubMedCrossRefGoogle Scholar
  31. 31.
    Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7:887–94.PubMedCrossRefGoogle Scholar
  32. 32.
    Dubray C, Ibrahim SA, Abdelmutalib M, et al. Treatment of severe malnutrition with 2-day intramuscular ceftriaxone vs 5-day amoxicillin. Ann Trop Paediatr. 2008;28:13–22.PubMedCrossRefGoogle Scholar
  33. 33.
    Robinson P. Controlled trial of aureomycin in premature twins and triplets. Lancet. 1952;259:52.CrossRefGoogle Scholar
  34. 34.
    Haight TH, Pierce WE. Effect of prolonged antibiotic administration of the weight of healthy young males. J Nutr. 1955;56:151–61.PubMedGoogle Scholar
  35. 35.
    Patterson PR. Minocycline in the antibiotic regimen of cystic fibrosis patients: weight gain and clinical improvement. Clin Pediatr [Phila]. 1977;16:60–3.CrossRefGoogle Scholar
  36. 36.
    Pirzada OM, McGaw J, Taylor CJ, Everard ML. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics. J Cyst Fibros. 2003;2:69–71.PubMedCrossRefGoogle Scholar
  37. 37.
    Southern KW, Barker PM, Solis-Moya A, Patel L. Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev. 2011;12:CD002203.PubMedGoogle Scholar
  38. 38.
    Saiman L, Mayer-Hamblett N, Anstead M, et al. Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa. Pediatr Pulmonol. 2012;47:641–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Mansi Y, Abdelaziz N, Ezzeldin Z, Ibrahim R. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants. Neonatology. 2011;100:290–4.PubMedCrossRefGoogle Scholar
  40. 40.
    Garly ML, Bale C, Martins CL, et al. Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau. BMJ. 2006;333:1245.PubMedCrossRefGoogle Scholar
  41. 41.
    Lane JA, Murray LJ, Harvey IM, et al. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther. 2011;33:922–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Cho I, Yamanishi S, Cox L, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012;488:621–6.PubMedCrossRefGoogle Scholar
  43. 43.
    •• Trasande L, Blustein J, Liu M, et al. Infant antibiotic exposures and early-life body mass. Int J Obes [Lond]. 2012 Aug 21. Epub ahead of print. A study that confirm the hypothesized link between antibiotic in early infancy and overweight in childhood.Google Scholar
  44. 44.
    Thuny F, Richet H, Casalta JP, et al. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One. 2010;5:e9074.PubMedCrossRefGoogle Scholar
  45. 45.
    Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6:e280.PubMedCrossRefGoogle Scholar
  46. 46.
    Dunham H, Casas I, Edens F, et al. Avian growth depression in chickens induced by environmental, microbiological, or nutritional stress is moderated by probiotic administrations of Lactobacillus reuteri. Biosci Microflora. 1998;17:133–9.Google Scholar
  47. 47.
    Nahashon SN, Nakaue HS, Snyder SP, Mirosh LW. Performance of single comb White Leghorn layers fed corn-soybean meal and barley-corn-soybean meal diets supplemented with a direct-fed microbial. Poult Sci. 1994;73:1712–23.PubMedCrossRefGoogle Scholar
  48. 48.
    Robinson EL, Thompson WL. Effect on weight gain of the addition of Lactobacillus acidophilus to the formula of newborn infants. J Pediatr. 1952;41:395–8.PubMedCrossRefGoogle Scholar
  49. 49.
    •• Kadooka Y, Sato M, Imaizumi K, et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr. 2010;64:636–43. The first randomized control trial linking Lactobacillus administration and a significant anti-obesity effect in humans.PubMedCrossRefGoogle Scholar
  50. 50.
    Lee K, Paek K, Lee HY, et al. Antiobesity effect of trans-10, cis-12-conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese mice. J Appl Microbiol. 2007;103:1140–6.PubMedCrossRefGoogle Scholar
  51. 51.
    • Abrahamsson TR, Sinkiewicz G, Jakobsson T, et al. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. J Pediatr Gastroenterol Nutr. 2009;49:349–54. Study establishing that probiotic administration during infancy lead to protracted alteration of the gut microbiota in humans.PubMedCrossRefGoogle Scholar
  52. 52.
    Nagpal R, Kumar A, Kumar M, et al. Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiol Lett. 2012 May 9. Epub ahead of print.Google Scholar
  53. 53.
    Robinson CJ, Young VB. Antibiotic administration alters the community structure of the gastrointestinal micobiota. Gut Microbes. 2010;1:279–84.PubMedCrossRefGoogle Scholar
  54. 54.
    Patrone V, Ferrari S, Lizier M, et al. Short-term modifications in the distal gut microbiota of weaning mice induced by a high-fat diet. Microbiology. 2012;158:983–92.PubMedCrossRefGoogle Scholar
  55. 55.
    Klare I, Konstabel C, Werner G, et al. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J Antimicrob Chemother. 2007;59:900–12.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, CNRS UMR 7278, IRD 198, Faculté de MédecineAix-Marseille UniversitéMarseilleFrance

Personalised recommendations